Your browser doesn't support javascript.
loading
Radiological complete remission in HER2-positive metastatic breast cancer patients: what to do with trastuzumab?
Steenbruggen, T G; Bouwer, N I; Smorenburg, C H; Rier, H N; Jager, A; Beelen, K; Ten Tije, A J; de Jong, P C; Drooger, J C; Holterhues, C; Kitzen, J J E M; Levin, M -D; Sonke, G S.
Afiliación
  • Steenbruggen TG; Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
  • Bouwer NI; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
  • Smorenburg CH; Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
  • Rier HN; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
  • Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Beelen K; Department of Internal Medicine, Reinier de Graaf Hospital, Delft, The Netherlands.
  • Ten Tije AJ; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands.
  • de Jong PC; Department of Medical Oncology, Sint Antonius Hospital, Utrecht, Utrecht, The Netherlands.
  • Drooger JC; Department of Medical Oncology, Ikazia Hospital, Rotterdam, The Netherlands.
  • Holterhues C; Department of Internal Medicine, Haga Hospital, The Hague, The Netherlands.
  • Kitzen JJEM; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
  • Levin M-; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
  • Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. g.sonke@nki.nl.
Breast Cancer Res Treat ; 178(3): 597-605, 2019 Dec.
Article en En | MEDLINE | ID: mdl-31493033

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Trastuzumab / Antineoplásicos Inmunológicos Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Trastuzumab / Antineoplásicos Inmunológicos Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Países Bajos